References
- Amin, T. and T. R. Hirst. 1994. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Protein Expr. Purif. 5: 198-204. https://doi.org/10.1006/prep.1994.1031
- Cregg, J. M., J. F. Tschopp, C. Stillman, R. Siegel, M. Akong, W. S. Craig, et al. 1987. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris. BioTechnology 5: 479-485. https://doi.org/10.1038/nbt0587-479
- Cregg, J. M., T. S. Vedvick, and W. C. Raschke. 1993. Recent advances in the expression of foreign genes in Pichia pastoris. BioTechnology 11: 905-910. https://doi.org/10.1038/nbt0893-905
- de Haan, L., W. R. Verweij, I. K. Feil, M. Holtrop, W. G. Hol, E. Agsteribbe, and J. Wilschut. 1998. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology 94: 424-430. https://doi.org/10.1046/j.1365-2567.1998.00535.x
- Douce, G., M. Fontana, M. Pizza, R. Rappuoli, and G. Dougan. 1997. Intranasal immunogenicity and adjuvanticity of sitedirected mutant derivatives of cholera toxin. Infect. Immun. 65: 2821-2828.
- Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. U.S.A. 92: 1644-1648. https://doi.org/10.1073/pnas.92.5.1644
- Feil, I. K., R. Reddy, L. de Haan, E. A. Merritt, F. van den Akker, D. R. Storm, and W. G. Hol. 1996. Protein engineering studies of A-chain loop 47-56 of Escherichia coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity. Mol. Microbiol. 20: 823-832. https://doi.org/10.1111/j.1365-2958.1996.tb02520.x
- Fingerut, E., B. Gutter, R. Meir, D. Eliahoo, and J. Pitcovski. 2005. Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast. Vaccine 23: 4685-4996. https://doi.org/10.1016/j.vaccine.2005.03.050
- Green, E. A., C. Botting, H. M. Webb, T. R. Hirst, and R. E. Randall. 1996. Construction, purification and immunogenicity of antigen-antibody-LTB complexes. Vaccine 14: 949-458. https://doi.org/10.1016/0264-410X(96)00039-4
- Holmgren, J., M. Lindblad, P. Fredman, L. Svennerholm, and H. Myrvold. 1985. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 89: 27-35.
- Isaka, M., T. Komiya, M. Takahashi, Y. Yasuda, T. Taniguchi, Y. Zhao, et al. 2004. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine. Vaccine 22: 3061-3068. https://doi.org/10.1016/j.vaccine.2004.02.019
- Isaka, M., Y. Yasuda, S. Kozuka, T. Taniguchi, Y. Miura, K. Matano, N. Goto, and K. Tochikubo. 1999. Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid. Vaccine 17: 944-948. https://doi.org/10.1016/S0264-410X(98)00280-1
- Kozuka, S., Y. Yasuda, M. Isaka, N. Masaki, T. Taniguchi, K. Matano, et al. 2000. Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity. Vaccine 18: 1730-1737. https://doi.org/10.1016/S0264-410X(99)00547-2
- Ma, X., W. Zheng, T. Wang, D. Wei, and Y. Ma. 2006. Optimization and high-level expression of a functional GSTtagged rHLT-B in Escherichia coli and GM1 binding ability of purified rHLT-B. J. Microbiol. 44: 293-300.
- Millar, D. G., T. R. Hirst, and D. P. Snider. 2001. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its closely related homologue, the B subunit of cholera toxin. Infect Immun. 69: 3476-3482. https://doi.org/10.1128/IAI.69.5.3476-3482.2001
- Nashar, T. O., H. M. Webb, S. Eaglestone, N. A. Williams, and T. R. Hirst. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad Sci. U.S.A. 93: 226-230. https://doi.org/10.1073/pnas.93.1.226
- Pizza, M., M. M. Giuliani, M. R. Fontana, E. Monaci, G. Douce, G. Dougan, K. H. Mills, R. Rappuoli, and G. Del Giudice. 2001. Mucosal vaccines: Non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19: 2534-2541. https://doi.org/10.1016/S0264-410X(00)00553-3
- Rezaee, M. A., A. Rezaee, S. M. Moazzeni, A. H. Salmanian, Y. Yasuda, K. Tochikubo, S. N. Pirayeh, and M. Arzanlou. 2005. Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in Saccharomyces cerevisiae. J. Microbiol. 43: 354-360.
- Richards, C. M., A. T. Aman, T. R. Hirst, T. J. Hill, and N. A. Williams. 2001. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 75: 1664-1671. https://doi.org/10.1128/JVI.75.4.1664-1671.2001
- Ruitenberg, K. M., J. R. Gilkerson, J. E. Wellington, D. N. Love, and J. M. Whalley. 2001. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease. Virus Res. 79: 125-135. https://doi.org/10.1016/S0168-1702(01)00337-9
- Sagt, C. M., B. Kleizen, R. Verwaal, M. D. de Jong, W. H. Muller, A. Smits, et al. 2000. Introduction of an N-glycosylation site increases secretion of heterologous proteins in yeasts. Appl. Environ. Microbiol. 66: 4940-4944. https://doi.org/10.1128/AEM.66.11.4940-4944.2000
- Scorer, C. A., J. J. Clare, W. R. McCombie, M. A. Romanos, and K. Sreekrishna. 1994. Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. BioTechnology 12: 181-184. https://doi.org/10.1038/nbt0294-181
- Sixma, T. K., S. E. Pronk, K. H. Kalk, E. S. Wartna, B. A. van Zanten, B. Witholt, and W. G. Hol. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351: 371-377. https://doi.org/10.1038/351371a0
- Sreekrishna, K., L. Nelles, R. Potenz, J. Cruze, P. Mazzaferro, W. Fish, et al. 1989. High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris. Biochemistry 28: 4117-4125. https://doi.org/10.1021/bi00435a074
- Stoscheck, C. M. 1990. Quantitation of protein. Methods Enz. 182: 50-68. https://doi.org/10.1016/0076-6879(90)82008-P
- Takahashi, I., H. Kiyono, R. J. Jackson, K. Fujihashi, H. F. Staats, S. Hamada, J. D. Clements, K. L. Bost, and J. R. McGhee. 1996. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect. Immun. 64: 1290-1298.
- Tschopp, J. F., G. Sverlow, R. Kosson, W. Craig, and L. Grinna. 1987. High-level secretion of glycosylated invertase in the methylotrophic yeast, Pichia pastoris. BioTechnology 5: 1305-1308. https://doi.org/10.1038/nbt1287-1305
- Verweij, W. R., L. de Haan, M. Holtrop, E. Agsteribbe, R. Brands, G. J. van Scharrenburg, and J. Wilschut. 1998. Mucosal immunoadjuvant activity of recombinant Escherichia coli heatlabile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 16: 2069-2076. https://doi.org/10.1016/S0264-410X(98)00076-0
Cited by
- Discovery of the cell-penetrating function of A2 domain derived from LTA subunit of Escherichia coli heat-labile enterotoxin vol.100, pp.11, 2010, https://doi.org/10.1007/s00253-016-7423-x